{
    "clinical_study": {
        "@rank": "154838", 
        "acronym": "MELODY-1", 
        "arm_group": [
            {
                "arm_group_label": "Macitentan", 
                "arm_group_type": "Experimental", 
                "description": "oral tablet, 10 mg once daily."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Matching placebo, once daily."
            }
        ], 
        "brief_summary": {
            "textblock": "Study to evaluate if macitentan is safe and tolerable enough to be used for treatment of\n      subjects with combined pre- and post-capillary pulmonary hypertension (CpcPH) due to left\n      ventricular dysfunction."
        }, 
        "brief_title": "Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension Due to Left Ventricular Dysfunction", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pre-capillary Pulmonary Hypertension", 
            "Post-capillary Pulmonary Hypertension", 
            "Left Ventricular Dysfunction"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Hypertension, Pulmonary", 
                "Ventricular Dysfunction, Left", 
                "Ventricular Dysfunction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Males and Females >=18 years of age\n\n          2. Subjects with combined pre-and post-capillary Pulmonary Hypertension (CpcPH) due to\n             left ventricular dysfunction (subset of WHO groups 2.1 and 2.2)\n\n          3. Optimized diuretic therapy\n\n        Exclusion Criteria:\n\n          1. Types of Pulmonary Hypertension other than WHO groups 2.1 and 2.2 (Nice\n             classification)\n\n          2. Administration of PAH-specific therapy (i.e., Endothelin receptor antagonists (ERAs),\n             Prostanoids, Phosphodiesterase 5 (PDE-5) inhibitors, guanylate cyclase stimulators)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070991", 
            "org_study_id": "AC-055G201"
        }, 
        "intervention": [
            {
                "arm_group_label": "Macitentan", 
                "description": "oral tablet, 10 mg once daily", 
                "intervention_name": "Macitentan", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Macitentan", 
                    "ACT-064992"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "matching placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "matching placebo"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Left heart failure LLT", 
            "Pulmonary Hypertension LLT", 
            "CpcPH"
        ], 
        "lastchanged_date": "February 24, 2014", 
        "location": [
            {
                "contact": {
                    "email": "roudiz@labiomed.org", 
                    "last_name": "Ronald Oudiz", 
                    "phone": "310-222-2515"
                }, 
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90502"
                    }, 
                    "name": "LIU Center for Pulmonary Hypertension"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "mcco3526@bellsouth.net", 
                    "last_name": "John W. McConnell", 
                    "phone": "502-587-8000"
                }, 
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40202"
                    }, 
                    "name": "Kentuckiana Pulmonary Associates"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "hfarber@bu.edu", 
                    "last_name": "Harrison W Farber", 
                    "phone": "617-638-4860"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }, 
                    "name": "Boston University School of Medicine"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "vmclaugh@med.umich.edu", 
                    "last_name": "Vallerie McLaughlin", 
                    "phone": "734-936-5383"
                }, 
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48109"
                    }, 
                    "name": "University of Michigan Internal Medicine Cardiology, Pulmonary Hypertension Program"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "yochaiad@clalit.org.il", 
                    "last_name": "Yochai Adir", 
                    "phone": "972-4-8250517"
                }, 
                "facility": {
                    "address": {
                        "city": "Haifa", 
                        "country": "Israel", 
                        "zip": "34362"
                    }, 
                    "name": "Carmel Medical Center, Pulmonary Unit"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "neville@hadassah.org.il", 
                    "last_name": "Neville Berkman", 
                    "phone": "+972 2 677 77 83"
                }, 
                "facility": {
                    "address": {
                        "city": "Jerusalem", 
                        "country": "Israel", 
                        "zip": "91120"
                    }, 
                    "name": "Institute of Pulmonology Hadassah Medical Centre : Ein Karem"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "daniel_s@clalit.org.il", 
                    "last_name": "Daniel Starobin", 
                    "phone": "+972 8 9441211"
                }, 
                "facility": {
                    "address": {
                        "city": "Rehovot", 
                        "country": "Israel", 
                        "zip": "76100"
                    }, 
                    "name": "Kaplan Medical Centre / Pulmonary Institute and Department of Medicine"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Michael.Segel@gmail.com", 
                    "last_name": "Michael Segel", 
                    "phone": "+972-3-530-3030"
                }, 
                "facility": {
                    "address": {
                        "city": "Tel-Hashomer", 
                        "country": "Israel", 
                        "zip": "52621"
                    }, 
                    "name": "The Chaim Sheba Medical Center / The Institute of Pulmonology, Physiology and Exercise"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "nazzareno.galie@unibo.it", 
                    "last_name": "Nazzareno Gali\u00e8", 
                    "phone": "+39 051 6363434"
                }, 
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "zip": "40138"
                    }, 
                    "name": "A.O. Universitaria Policlinico S. Orsola-Malpighi - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale - Unit\u00e0 Operativa di Cardiologia"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "fperez@clinic.ub.es", 
                    "last_name": "F\u00e9lix P\u00e9rez Villa", 
                    "phone": "+34 932275400 ext. 2035"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinic Servicio de Cardiologia"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "edrcg@hotmail.com", 
                    "last_name": "Enric Domingo Ribas", 
                    "phone": "+34 93 489 30 00"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08035"
                    }, 
                    "name": "Hospital Vall d\u00b4Hebron Servicio de Cardiologia"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "josem.arizon.sspa@juntadeandalucia.es", 
                    "last_name": "Jos\u00e9 Mar\u00eda Ariz\u00f3n del Prado", 
                    "phone": "+34 957 010 504"
                }, 
                "facility": {
                    "address": {
                        "city": "Cordoba", 
                        "country": "Spain", 
                        "zip": "14004"
                    }, 
                    "name": "Hospital Reina Sofia Servicio de Cardiologia"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "mangomezs@telefonica.net", 
                    "last_name": "Miguel Angel Gomez Sanchez", 
                    "phone": "(+) 34 91390 8289"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28041"
                    }, 
                    "name": "Hospital Universitario 12 Octubre Servicio de Cardiolog\u00eda"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Israel", 
                "Italy", 
                "Spain"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction", 
        "overall_official": {
            "affiliation": "Actelion", 
            "last_name": "S\u00e9bastien Roux, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Austria: Federal Office for Safety in Health Care", 
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Czech Republic: State Institute for Drug Control", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Israel: Ethics Commission", 
                "Italy: The Italian Medicines Agency", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Switzerland: Swissmedic", 
                "Canada: Health Canada"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Proportion of subjects experiencing one of the following up to EOT:\nSignificant fluid retention, defined as one of the following:\nIncrease in body weight at any time by \u2265 5% or \u2265 5 kg from baseline due to fluid overload.\nParenteral administration of diuretics.\nWorsening in NYHA functional class from baseline.", 
            "measure": "To evaluate the safety and tolerability of macitentan 10 mg in subjects with CpcPH", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline to End of Study (30 days after last dose)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070991"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "PVR at rest at Week 12 expressed as percent of baseline PVR at rest. Change from baseline to Week 12 in mean right atrial pressure, mPAP, cardiac index, cardiac output, total pulmonary resistance, transpulmonary gradient (TPG [mPAP \u2212 PAWP]), DPG and mixed venous oxygen saturation at rest. Change from baseline to Week 12 in echocardiographic parameters of diastolic and systolic function (i.e., LVEF, tricuspid annular plane systolic excursion, tricuspid regurgitation velocity, diastolic wall thickness of the septum and the left ventricular free wall, E/e' ratio, left atrial volume).", 
            "measure": "To evaluate the efficacy of macitentan 10 mg in subjects with CpcPH", 
            "safety_issue": "No", 
            "time_frame": "Baseline to Week 12"
        }, 
        "source": "Actelion", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Actelion", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}